Thomas Hudson
Chief Tech/Sci/R&D Officer bij ABBVIE INC.
Vermogen: 20 M $ op 31-03-2024
Profiel
Thomas J. Hudson, oprichter van McGill University & Gnome Qubec Innovation Centre, is Chief Scientific Officer, Senior VP-R&D bij AbbVie, Inc. Hij is ook wetenschappelijk directeur bij het P3G Consortium en professor aan de Universiteit van Toronto. In het verleden was hij President & Wetenschappelijk Directeur bij het Ontario Institute for Cancer Research, Assistent Directeur-Center for Genome Research bij het Whitehead Institute for Biomedical Research en Directeur bij McGill University & Gnome Qubec Innovation Centre.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ABBVIE, INC.
0.01% | 28-02-2024 | 107 267 ( 0.01% ) | 20 M $ | 31-03-2024 |
Actieve functies van Thomas Hudson
| Bedrijven | Functie | Begin |
|---|---|---|
| ABBVIE INC. | Chief Tech/Sci/R&D Officer | 01-07-2019 |
| University of Toronto | Corporate Officer/Principal | 01-01-2007 |
| P3G Consortium | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Thomas Hudson
| Bedrijven | Functie | Einde |
|---|---|---|
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | President | 01-01-2016 |
| McGill University & Génome Québec Innovation Centre | Founder | 01-01-2011 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2001 |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Opleiding van Thomas Hudson
| University of Montréal | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
| P3G Consortium |
